Clinical Trial Update: A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SHR-A1811 for HER2-positive biliary tract cancer (locally advanced or metastatic) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer | Phase 2 | Status: RECRUITING